您的位置: 首页 > 农业专利 > 详情页

EFFET PROTECTEUR DE DMPC, DMPG, DMPC/DMPG, EGPG, LYSOPG ET LYSOPC CONTRE DES MÉDICAMENTS PROVOQUANT DES CANALOPATHIES
专利权人:
Avanti Polar Lipids Inc.;Signpath Pharma Inc.
发明人:
申请号:
EP15803421.5
公开号:
EP3151837A4
申请日:
2015.06.03
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
The present invention includes compositions and methods for preventing one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by an active agent or a drug in a human or animal subject comprising: an amount of a lysophosphatidyl compound adapted for oral administration effective to reduce or prevent one or more cardiac channelopathies or conditions resulting from irregularities or alterations in cardiac patterns caused by the active agent or drug. Such compositions may further comprise a monoglyceride, a free fatty acid or a combination of the foregoing, including, e.g., a eutectic mixture.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充